-
-
On Aug. 26, Fosun Pharma reported 2010 interim, indicating Fosun Pharma has achieved main business revenue RMB 2,169,002,700.00, increased 23.71% YoY during the reporting period; achieved net profits attributable to parent company RMB 551,000,000.00 and increased 60.75% YoY; ...
|